Showing posts with label Diseases & Conditions. Show all posts
Showing posts with label Diseases & Conditions. Show all posts

Monday 14 April 2014

HIV-1 Infection - Pipeline Review, H1 Market Trends, Estimates And Forecasts 2014: Industrial Report

MarketResearchReports.Biz presents this most up-to-date research on "Research Report On HIV-1 Infection - Pipeline Review, H1 Market" 2014

HIV-1 Infection - Pipeline Review, H1 2014, provides an overview of the HIV-1 Infections therapeutic pipeline.


This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV-1 Infection and special features on late-stage and discontinued projects.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/hiv-1-infection-pipeline-review-h1-2014

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/195027

Scope

- The report provides a snapshot of the global therapeutic landscape of HIV-1 Infection
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for HIV-1 Infection and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the HIV-1 Infection products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the HIV-1 Infection pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

To Read Complete Report with TOC: http://www.marketresearchreports.biz/sample/sample/195027

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for HIV-1 Infection
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding HIV-1 Infection pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/

Friday 11 April 2014

Treatment For Syndromes Of Progressive Ataxia And Weakness Disorders Market Growth & Forecast Attractiveness 2013 - 2019: Top Rated Report

Treatment For Syndromes Of Progressive Ataxia And Weakness Disorders Market - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 - 2019

Progressive ataxia and weakness disorders are related to damage, degeneration or loss of neurons of the brain which leads to muscle coordination disability. The market for treatments for syndromes of progressive ataxia and weakness disorders is growing rapidly over the last few years. Some of the major key factors driving the market are novel drug development, rapid technological changes and increased collaborations among industry players towards development of new therapies. Key technological changes involved in market growth are protein misfolding, gene mutation and stem cell therapy. However, recent patent expiries of major drugs are the major restraints for this market.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/treatment-for-syndromes-of-progressive-ataxia-and-weakness-disorders-market-global-industry-analysis-size-share-growth-trend-and-forecast-2013-2019

The market is primarily divided into three segments: market by dysfunction or disorders, market by region and the market by technology. Dysfunction or disorders sub-segment include major diseases, such as Friedreich's ataxia, Machado Joseph disease, Hereditary neuropathies, Progressive bulbar palsy and Multiple sclerosis. Regional sub-segment includes market overview, market share and revenue of different region of the world. Technological sub-segment comprises small molecule and monoclonal antibody techniques.

Some of the major players in this market are Abbott, Biogen, Bristol-Myers, Dr. Reddy Laboratories, Eli Lilly, GlaxoSmithKline, Merck, Pfizer and Roche.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/toc/194540

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

•    North America
•    Asia Pacific
•    Europe
•    Rest of the World 

This report provides comprehensive analysis of

•    Market growth drivers
•    Factors limiting market growth
•    Current market trends
•    Market structure
•    Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/194540

Reasons for Buying this Report


•    This report provides pin-point analysis for changing competitive dynamics
•    It provides a forward looking perspective on different factors driving or restraining market growth
•    It provides a technological growth map over time to understand the industry growth rate
•    It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
•    It helps in understanding the key product segments and their future
•    It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
•    It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
•    It provides distinctive graphics and exemplified SWOT analysis of major market segments


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/

Treatment For Syndromes Of Dementia And Movement Disorders Market Competitive Landscape 2013 - 2019: New Released Report

Treatment For Syndromes Of Dementia And Movement Disorders Market - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 - 2019

Dementia is a serious brain disorder or damage which leads to memory loss, language and thinking ability. The global market for treatment

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/treatment-for-syndromes-of-dementia-and-movement-disorders-market-global-industry-analysis-size-share-growth-trend-and-forecast-2013-2019

The global market for treatments for syndromes of Dementia and movement disorders is primarily concentrated on neurodegenerative disorder, which include treatment and therapies for progressive dementia, neurological abnormalities and movement disorders. Some of the key factors driving the growth of this market are increasing prevalence of neurodegenerative diseases, increase in R&D spending, patent expiry of many blockbuster drugs and emergence of new technologies

The market for treatments for syndromes of Dementia and movement disorders comprises two segments: Neurodegenerative disease based drug treatment and Technological treatment. Neurodegenerative diseases include Alzheimer’s disease, Lewy body dementia, Pick’s disease, Huntington’s disease, Parkinson’s disease, etc. Technological area of treatment include immunization strategy, tau tangling inhibitors, biomarkers and monoclonal antibodies.

Some of the key players operating in the market for treatment for syndromes of Dementia and movement disorders are Abbott, Accera, Cadila, Cipla, Eli Lilly, GlaxoSmithKline and Dr. Reddy Laboratories.  

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/toc/194539

s for syndromes of Dementia is witnessing a significant growth in last few years. Rapid technological advancement with increasing number of research in the area of Dementia and other movement disorders are supporting growth to the market. Many pharmaceutical companies are collaborating with research institutes in order to develop new and advanced treatment for syndromes of dementia.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
 
•    North America
•    Asia Pacific
•    Europe
•    Rest of the World 

This report provides comprehensive analysis of

•    Market growth drivers
•    Factors limiting market growth
•    Current market trends
•    Market structure
•    Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/194539

Reasons for Buying this Report


•    This report provides pin-point analysis for changing competitive dynamics
•    It provides a forward looking perspective on different factors driving or restraining market growth
•    It provides a technological growth map over time to understand the industry growth rate
•    It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
•    It helps in understanding the key product segments and their future
•    It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
•    It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
•    It provides distinctive graphics and exemplified SWOT analysis of major market segments


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://market-recent-report.blogspot.com/

Thursday 22 August 2013

Research Report: Global Industry Inflammatory Bowel Disease Market Share 2013-2019



Inflammatory bowel disease (IBD) is an immune-mediated disease in which the body’s own immune system attacks the parts of the digestive system of the human body. Such disease involves inflammation of lower gastrointestinal tract and causes irreversible damage to the bowel. Ulcerative colitis and Crohn’s disease are the two major forms of IBD; both having distinct pathologic and clinical characteristics. IBD is a difficult to manage medical condition with a higher morbidity rate and thus its diagnosis and management is of utmost importance. 


The global inflammatory bowel disease market is categorized as follows:

Application

  • Therapeutic
  • Diagnostic

Diseased condition

  • Crohns disease
  • Ulcerative colitis

Product type

  • Aminosalicylates
  • Antibiotics
  • Corticosteroids
  • Biologic therapies (biological drugs)
  • Immunomodulators

Currently, the developed global markets of North America and Europe make up for the majority of the inflammatory bowel disease market in the world. Emerging markets of Asia mainly India, Russia and Japan as well as countries of Middle East and Latin America are also expected to show strong growth due to rising incidences of such diseases owing to increased industrialization, modernization of the population and drastic lifestyle changes.

One of the key factors driving the growth of this market is the increase in use of biological therapies such as monoclonal antibodies. However, difficulties involved in affording the expensive treatments of such diseases may pose challenge to growth of inflammatory bowel diseases market majorly in developing nations.

Some of the key players in this industry are Abbott Laboratories, Amgen, Inc., Bristol-Myers Squibb Company, Alcon, Inc., Baxter International, Inc., Johnson & Johnson, Sequella, Inc., Sanofi-Aventis LLC, Osiris Therapeutics, Inc., AstraZeneca PLC, Eisai Co. Ltd., Cephalon, Inc., Celltrion, Inc., Pfizer, Inc., Pluristem Therapeutics, Inc., Soligenix, Inc. and Ore Pharmaceuticals, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/172858

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments


Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948

Thursday 8 August 2013

Popular Market Report: Global Parkinson\'s Disease Market Size 2012-2016: Market Research Report


Description

TechNavio's analysts forecast the Global Parkinson's Disease market to grow at a CAGR of 1.67 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the aging population. The Global Parkinson’s Disease market has also been witnessing the transition toward using drugs that have new mechanisms of action. However, weak pipeline landscape could pose a challenge to the growth of this market.




TechNavio's report, the Global Parkinson's Disease Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Parkinson's Disease market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include GlaxoSmithKline plc, Novartis AG, Orion Corp., and Teva Pharmaceuticals Industries Ltd.

The other vendors mentioned in the report are AbbVie Inc., Acadia Pharmaceuticals Inc., Avicena Group Inc., BoehringerIngelheim GmbH, Impax Laboratories Inc., Lundbeck A/S, Newron Pharmaceuticals SpA, Solvay Pharmaceuticals Inc., and Valeant International SRL.


To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172661         


TABLE OF CONTENT

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology
Market Research Process
Research Design
Research Methodology

5. Scope of the Report
Market Overview
Product Offerings


Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948

Monday 8 July 2013

New Report: Global Industry Respiratory Disease Testing Market Forecast 2012 - 2018


Respiratory diseases are defined as the diseases that affect the nasal passage, air passage, lungs and the bronchi. Respiratory diseases range from acute condition such as common cold, pneumonia, bronchitis to chronic conditions such as chronic pulmonary obstructive diseases (COPD) and asthma. Onset of respiratory infection is provoked by number of causative agent’s namely viral pathogens, bacterial pathogens, smoking, allergens and occupational agents.




As cited by World Health Organization (WHO), respiratory disease has become one of the most common causes of deaths worldwide. Complications in breathing severely affect the quality of life of the patients and so rising prevalence of respiratory diseases across the globe possesses a serious threat. Asthma, a chronic disease characterized by recurrent attacks of breathlessness and COPD is a life threatening lung disease that interferes with the normal breathing. It has been estimated that currently, more than 235 million people are suffering from asthma and about 64 million people are diagnosed with COPD. Nowadays, occurrence of respiratory diseases is common in both the gender owing to increased usage of tobacco and exposure to smoke of biomass fuels used for cooking.

People suffering from the respiratory diseases require healthcare services from primary consultations to hospital admission. Thus, with the increase in demand for treatment of respiratory diseases manufactures are developing testing devices which can diagnose the diseases at an early stage. Simple diagnostic tests such as spirometer, peak flow meters, polysomnography devices and other diagnostic devices are available in the market to cater the unmet needs. For further controlling the mortality rate companies are entering into collaborations for launching diagnostic tests. Usages of these tests are procured by hospitals, physician’s offices, private/commercial labs and public health labs.

North America accounts for a larger share among all the geographies followed by Europe owing to increase in aging population, smoking and rising incidences of common COPD. However, due to increase in smoking rate, Asian countries also holds a significant share in respiratory disease testing market.

The emergence in this market is expected to show a double digit growth in the coming years owing to demographic changes, increase in the COPD cases and technological advancements which will influence the growth of this market. In addition with the growing demand for long term treatment and managing the condition acts as a driver for the growth of this market. Some of the key players in the respiratory diseases testing market include Abott, Beckman Coulter, affymetrix, biomeriux and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 




To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/170579  

About Us


MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948